

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 9.25608672 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 7.84916073 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.57969862 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.74966479 |
| 5 | cellular response to zinc ion (GO:0071294) | 6.61188205 |
| 6 | regulation of B cell differentiation (GO:0045577) | 6.27662258 |
| 7 | B cell proliferation (GO:0042100) | 6.01946664 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.62740025 |
| 9 | positive thymic T cell selection (GO:0045059) | 5.51170372 |
| 10 | mature B cell differentiation (GO:0002335) | 5.45500124 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 5.38242262 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.21412128 |
| 13 | negative regulation of B cell proliferation (GO:0030889) | 5.09665805 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.09455235 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.09455235 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.93268261 |
| 17 | regulation of B cell proliferation (GO:0030888) | 4.90737784 |
| 18 | cytidine deamination (GO:0009972) | 4.65584161 |
| 19 | cytidine metabolic process (GO:0046087) | 4.65584161 |
| 20 | cytidine catabolic process (GO:0006216) | 4.65584161 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.64170767 |
| 22 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.45967063 |
| 23 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.40261591 |
| 24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.38749818 |
| 25 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.36062516 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.34915906 |
| 27 | B cell homeostasis (GO:0001782) | 4.23667177 |
| 28 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.22556883 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 4.20784004 |
| 30 | detection of bacterium (GO:0016045) | 4.20332059 |
| 31 | regulation of B cell apoptotic process (GO:0002902) | 4.19475350 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.17285153 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.16976836 |
| 34 | positive regulation of B cell proliferation (GO:0030890) | 4.13583924 |
| 35 | detection of other organism (GO:0098543) | 4.10279132 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.10189723 |
| 37 | response to interleukin-15 (GO:0070672) | 4.08612070 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.05069949 |
| 39 | mature B cell differentiation involved in immune response (GO:0002313) | 3.99600412 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.99040970 |
| 41 | germinal center formation (GO:0002467) | 3.96051711 |
| 42 | neutrophil activation (GO:0042119) | 3.95939746 |
| 43 | positive T cell selection (GO:0043368) | 3.95043058 |
| 44 | regulation of platelet aggregation (GO:0090330) | 3.92471589 |
| 45 | * B cell activation (GO:0042113) | 3.86291428 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 3.85239980 |
| 47 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.84411598 |
| 48 | positive regulation of Rap GTPase activity (GO:0032854) | 3.83809911 |
| 49 | thymic T cell selection (GO:0045061) | 3.81198864 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.79824200 |
| 51 | positive regulation of interferon-alpha production (GO:0032727) | 3.79384834 |
| 52 | regulation of antigen processing and presentation (GO:0002577) | 3.79009517 |
| 53 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.76235606 |
| 54 | defense response to protozoan (GO:0042832) | 3.72131592 |
| 55 | lymph node development (GO:0048535) | 3.71122505 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 3.69574913 |
| 57 | negative T cell selection (GO:0043383) | 3.68022902 |
| 58 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.68022765 |
| 59 | B cell mediated immunity (GO:0019724) | 3.62653036 |
| 60 | positive regulation of B cell activation (GO:0050871) | 3.61219344 |
| 61 | regulation of B cell activation (GO:0050864) | 3.60720999 |
| 62 | lymphocyte homeostasis (GO:0002260) | 3.60333826 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 3.60259729 |
| 64 | regulation of germinal center formation (GO:0002634) | 3.59349718 |
| 65 | thrombin receptor signaling pathway (GO:0070493) | 3.56187504 |
| 66 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.56057790 |
| 67 | lymphocyte proliferation (GO:0046651) | 3.53358724 |
| 68 | positive regulation of granulocyte differentiation (GO:0030854) | 3.52723652 |
| 69 | T cell selection (GO:0045058) | 3.51833645 |
| 70 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.49787009 |
| 71 | mononuclear cell proliferation (GO:0032943) | 3.49784618 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.48921631 |
| 73 | mast cell activation (GO:0045576) | 3.48053768 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.47378787 |
| 75 | granulocyte activation (GO:0036230) | 3.44199489 |
| 76 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.42722719 |
| 77 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.42722719 |
| 78 | negative regulation of phagocytosis (GO:0050765) | 3.40785851 |
| 79 | negative regulation of B cell apoptotic process (GO:0002903) | 3.40751690 |
| 80 | myeloid cell activation involved in immune response (GO:0002275) | 3.39794150 |
| 81 | positive regulation of antigen processing and presentation (GO:0002579) | 3.39744152 |
| 82 | respiratory burst (GO:0045730) | 3.39722239 |
| 83 | negative regulation of histone methylation (GO:0031061) | 3.35320081 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 3.34789625 |
| 85 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.33126244 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.33106522 |
| 87 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.32484816 |
| 88 | B cell differentiation (GO:0030183) | 3.30980833 |
| 89 | negative regulation of cell killing (GO:0031342) | 3.30013159 |
| 90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30013159 |
| 91 | B cell activation involved in immune response (GO:0002312) | 3.27164957 |
| 92 | complement activation, classical pathway (GO:0006958) | 3.26845981 |
| 93 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.26506308 |
| 94 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.26506308 |
| 95 | modulation by symbiont of host immune response (GO:0052553) | 3.24720259 |
| 96 | positive regulation by symbiont of host defense response (GO:0052509) | 3.24720259 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 3.24720259 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.24720259 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.24720259 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.24720259 |
| 101 | leukocyte degranulation (GO:0043299) | 3.23029430 |
| 102 | positive regulation of interleukin-2 production (GO:0032743) | 3.20990018 |
| 103 | positive regulation of mast cell degranulation (GO:0043306) | 3.20646410 |
| 104 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.20646410 |
| 105 | positive regulation of macrophage differentiation (GO:0045651) | 3.16654282 |
| 106 | regulation of Rap GTPase activity (GO:0032317) | 3.16296073 |
| 107 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.16025808 |
| 108 | regulation of mast cell degranulation (GO:0043304) | 3.14882663 |
| 109 | macrophage activation involved in immune response (GO:0002281) | 3.12611119 |
| 110 | negative regulation of bone resorption (GO:0045779) | 3.12554608 |
| 111 | leukocyte proliferation (GO:0070661) | 3.12434161 |
| 112 | histamine secretion (GO:0001821) | 3.12426021 |
| 113 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.11869834 |
| 114 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.11869834 |
| 115 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.11869834 |
| 116 | microglial cell activation (GO:0001774) | 3.11812291 |
| 117 | cellular response to exogenous dsRNA (GO:0071360) | 3.11196666 |
| 118 | leukocyte homeostasis (GO:0001776) | 3.09854335 |
| 119 | T cell costimulation (GO:0031295) | 3.09790188 |
| 120 | positive regulation of immunoglobulin production (GO:0002639) | 3.08392381 |
| 121 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.07867879 |
| 122 | response to protozoan (GO:0001562) | 3.07754253 |
| 123 | T cell homeostasis (GO:0043029) | 3.06228951 |
| 124 | lymphocyte costimulation (GO:0031294) | 3.04195120 |
| 125 | regulation of platelet activation (GO:0010543) | 3.02394059 |
| 126 | positive regulation of type 2 immune response (GO:0002830) | 3.02290337 |
| 127 | humoral immune response (GO:0006959) | 3.01884355 |
| 128 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00132290 |
| 129 | I-kappaB phosphorylation (GO:0007252) | 2.99764626 |
| 130 | detection of external biotic stimulus (GO:0098581) | 2.99646297 |
| 131 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.99546484 |
| 132 | negative regulation of humoral immune response (GO:0002921) | 2.98871054 |
| 133 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.98031840 |
| 134 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.97027044 |
| 135 | positive regulation of DNA recombination (GO:0045911) | 2.96241768 |
| 136 | tolerance induction (GO:0002507) | 2.94593986 |
| 137 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.94508790 |
| 138 | leukocyte aggregation (GO:0070486) | 2.94419846 |
| 139 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.93495204 |
| 140 | autophagic vacuole fusion (GO:0000046) | 2.93343688 |
| 141 | dendritic cell chemotaxis (GO:0002407) | 2.93090618 |
| 142 | megakaryocyte development (GO:0035855) | 2.92490633 |
| 143 | cellular response to type I interferon (GO:0071357) | 2.91542494 |
| 144 | type I interferon signaling pathway (GO:0060337) | 2.91542494 |
| 145 | response to type I interferon (GO:0034340) | 2.90963072 |
| 146 | immune response-activating signal transduction (GO:0002757) | 2.90655955 |
| 147 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.90510093 |
| 148 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.89932986 |
| 149 | regulation of superoxide anion generation (GO:0032928) | 2.89329511 |
| 150 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.87811419 |
| 151 | dendritic cell migration (GO:0036336) | 2.86829938 |
| 152 | purinergic receptor signaling pathway (GO:0035587) | 2.86773496 |
| 153 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83655802 |
| 154 | hepatocyte apoptotic process (GO:0097284) | 2.82914719 |
| 155 | cellular extravasation (GO:0045123) | 2.81829878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.13255854 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.57321390 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.20581518 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.57847747 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 4.51408661 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.43861904 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.88618872 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50470135 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.44671852 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.35016746 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.07663764 |
| 12 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.07542507 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.97308143 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.94637236 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72565542 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71462917 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.56798028 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.53342248 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.52129352 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46095916 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.42190808 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34037343 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23153730 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.18006140 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17800951 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.16970217 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15431085 |
| 28 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.15396292 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.14846646 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.14120961 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 2.12321987 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.12219445 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.08826042 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01423946 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00667483 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.99094404 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99066557 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85405100 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84452139 |
| 40 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.82327048 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73872595 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72160818 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71575604 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71061155 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.68511763 |
| 46 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63089791 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61457172 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59012998 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55402432 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.51354615 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47829235 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46331353 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45988927 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.45890254 |
| 55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45620147 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39328825 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37073770 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36996871 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36746114 |
| 60 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31327493 |
| 61 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.29654472 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.28700090 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20514292 |
| 64 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17021104 |
| 65 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16892954 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16187583 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14050257 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09827086 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09235670 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08185835 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04079282 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02794339 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02423875 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00721302 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00333352 |
| 76 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98699116 |
| 77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95455239 |
| 78 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94874103 |
| 79 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93776652 |
| 80 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92888027 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92629239 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92403117 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92019987 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90799437 |
| 85 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90549106 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90180686 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89453286 |
| 88 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89220278 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.88974867 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87505189 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87292932 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86354143 |
| 93 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.86001994 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85812497 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85593101 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85487242 |
| 97 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84287402 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83550460 |
| 99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.82270191 |
| 100 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.81013988 |
| 101 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.80162383 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79611528 |
| 103 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78043334 |
| 104 | P300_27268052_Chip-Seq_Bcells_Human | 0.77583879 |
| 105 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77524460 |
| 106 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76893011 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74805700 |
| 108 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73632506 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73378694 |
| 110 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73338317 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73232666 |
| 112 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.72927180 |
| 113 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.72483740 |
| 114 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72361970 |
| 115 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.72297815 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72260923 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72056202 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71959335 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70638565 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.68387873 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68321016 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67686239 |
| 123 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.67548636 |
| 124 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.66482115 |
| 125 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.66239544 |
| 126 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66138129 |
| 127 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.66089149 |
| 128 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65783003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.91866550 |
| 2 | MP0001790_abnormal_immune_system | 5.09289225 |
| 3 | MP0005387_immune_system_phenotype | 5.09289225 |
| 4 | * MP0001800_abnormal_humoral_immune | 4.99473745 |
| 5 | MP0003724_increased_susceptibility_to | 3.98051099 |
| 6 | MP0000685_abnormal_immune_system | 3.84917291 |
| 7 | * MP0002452_abnormal_antigen_presenting | 3.81083974 |
| 8 | MP0003303_peritoneal_inflammation | 3.49527862 |
| 9 | MP0005000_abnormal_immune_tolerance | 3.43193378 |
| 10 | MP0005671_abnormal_response_to | 3.28640329 |
| 11 | * MP0002723_abnormal_immune_serum | 3.15742506 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 3.08850774 |
| 13 | * MP0001819_abnormal_immune_cell | 2.98348527 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.85372301 |
| 15 | * MP0000716_abnormal_immune_system | 2.65203926 |
| 16 | * MP0000689_abnormal_spleen_morphology | 2.57201643 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.34079367 |
| 18 | MP0008004_abnormal_stomach_pH | 2.26801865 |
| 19 | MP0002419_abnormal_innate_immunity | 2.18587496 |
| 20 | MP0005025_abnormal_response_to | 2.17933679 |
| 21 | * MP0002429_abnormal_blood_cell | 2.15090224 |
| 22 | MP0002722_abnormal_immune_system | 2.13324300 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.09707419 |
| 24 | MP0002396_abnormal_hematopoietic_system | 2.05132197 |
| 25 | MP0004510_myositis | 2.02711814 |
| 26 | MP0001873_stomach_inflammation | 2.01010720 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.97852993 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.97284981 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.93987594 |
| 30 | MP0001853_heart_inflammation | 1.79001423 |
| 31 | MP0009785_altered_susceptibility_to | 1.78507462 |
| 32 | MP0002405_respiratory_system_inflammati | 1.78308003 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.75840969 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.72193887 |
| 35 | MP0003436_decreased_susceptibility_to | 1.64426767 |
| 36 | MP0008057_abnormal_DNA_replication | 1.55908612 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.55047241 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.53648593 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.49507554 |
| 40 | MP0005310_abnormal_salivary_gland | 1.48903517 |
| 41 | MP0001851_eye_inflammation | 1.41482254 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.41010372 |
| 43 | MP0004947_skin_inflammation | 1.36887510 |
| 44 | MP0002006_tumorigenesis | 1.35627362 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.32175560 |
| 46 | MP0004381_abnormal_hair_follicle | 1.31652285 |
| 47 | MP0003787_abnormal_imprinting | 1.28820665 |
| 48 | MP0002933_joint_inflammation | 1.26494409 |
| 49 | MP0003866_abnormal_defecation | 1.25891263 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.25158024 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.15093271 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.10634912 |
| 53 | MP0000858_altered_metastatic_potential | 1.09723153 |
| 54 | MP0004883_abnormal_blood_vessel | 1.09416989 |
| 55 | MP0002136_abnormal_kidney_physiology | 1.07308313 |
| 56 | MP0004130_abnormal_muscle_cell | 1.05686796 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.04034652 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.02421537 |
| 59 | MP0002132_abnormal_respiratory_system | 1.01702715 |
| 60 | MP0008469_abnormal_protein_level | 1.00392402 |
| 61 | MP0003045_fibrosis | 0.98861366 |
| 62 | MP0003091_abnormal_cell_migration | 0.97519768 |
| 63 | MP0008260_abnormal_autophagy | 0.95869528 |
| 64 | MP0002909_abnormal_adrenal_gland | 0.94828384 |
| 65 | MP0002019_abnormal_tumor_incidence | 0.94189749 |
| 66 | MP0010094_abnormal_chromosome_stability | 0.93747890 |
| 67 | MP0002928_abnormal_bile_duct | 0.93171527 |
| 68 | MP0003077_abnormal_cell_cycle | 0.92377619 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 0.91226797 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 0.90236049 |
| 71 | MP0002095_abnormal_skin_pigmentation | 0.85072287 |
| 72 | MP0000343_altered_response_to | 0.84078659 |
| 73 | MP0000230_abnormal_systemic_arterial | 0.83916154 |
| 74 | MP0003011_delayed_dark_adaptation | 0.78432193 |
| 75 | MP0003252_abnormal_bile_duct | 0.76986315 |
| 76 | MP0008874_decreased_physiological_sensi | 0.75801418 |
| 77 | MP0003191_abnormal_cellular_cholesterol | 0.75676298 |
| 78 | MP0003172_abnormal_lysosome_physiology | 0.74832169 |
| 79 | MP0002998_abnormal_bone_remodeling | 0.71077400 |
| 80 | MP0009278_abnormal_bone_marrow | 0.70800113 |
| 81 | MP0008961_abnormal_basal_metabolism | 0.70498013 |
| 82 | MP0001765_abnormal_ion_homeostasis | 0.70004433 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.69873176 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.69300002 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.67261541 |
| 86 | MP0006082_CNS_inflammation | 0.65402774 |
| 87 | MP0005164_abnormal_response_to | 0.64084848 |
| 88 | MP0008872_abnormal_physiological_respon | 0.63523664 |
| 89 | MP0009764_decreased_sensitivity_to | 0.63388987 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 0.63141635 |
| 91 | MP0005451_abnormal_body_composition | 0.62277272 |
| 92 | MP0000249_abnormal_blood_vessel | 0.60761074 |
| 93 | MP0000490_abnormal_crypts_of | 0.60619475 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.60251165 |
| 95 | MP0003638_abnormal_response/metabolism_ | 0.59809914 |
| 96 | MP0003828_pulmonary_edema | 0.59155107 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.59071631 |
| 98 | MP0005621_abnormal_cell_physiology | 0.58582481 |
| 99 | MP0002168_other_aberrant_phenotype | 0.58352354 |
| 100 | MP0005166_decreased_susceptibility_to | 0.58089767 |
| 101 | MP0005075_abnormal_melanosome_morpholog | 0.57944680 |
| 102 | MP0006054_spinal_hemorrhage | 0.55617582 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.55550496 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.55395576 |
| 105 | MP0001663_abnormal_digestive_system | 0.54167857 |
| 106 | MP0008058_abnormal_DNA_repair | 0.53193823 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.52844115 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.52091903 |
| 109 | MP0000371_diluted_coat_color | 0.51947528 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.51607558 |
| 111 | MP0009765_abnormal_xenobiotic_induced | 0.51314719 |
| 112 | MP0003075_altered_response_to | 0.51271332 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.50385865 |
| 114 | MP0005397_hematopoietic_system_phenotyp | 0.49099414 |
| 115 | MP0001545_abnormal_hematopoietic_system | 0.49099414 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.48578981 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.48267963 |
| 118 | MP0000350_abnormal_cell_proliferation | 0.47243256 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.46983796 |
| 120 | MP0000609_abnormal_liver_physiology | 0.43996743 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.43450732 |
| 122 | MP0002135_abnormal_kidney_morphology | 0.42106227 |
| 123 | MP0000313_abnormal_cell_death | 0.42076017 |
| 124 | MP0002009_preneoplasia | 0.41896905 |
| 125 | MP0009763_increased_sensitivity_to | 0.41080521 |
| 126 | MP0002083_premature_death | 0.40436260 |
| 127 | MP0003111_abnormal_nucleus_morphology | 0.39941846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 9.28103096 |
| 2 | Gastrointestinal stroma tumor (HP:0100723) | 8.71945749 |
| 3 | Recurrent sinusitis (HP:0011108) | 6.42134770 |
| 4 | Colitis (HP:0002583) | 6.37448306 |
| 5 | Recurrent bronchitis (HP:0002837) | 6.15917438 |
| 6 | Cellulitis (HP:0100658) | 5.78353704 |
| 7 | IgM deficiency (HP:0002850) | 5.43237209 |
| 8 | Lymphopenia (HP:0001888) | 5.39512565 |
| 9 | Inflammation of the large intestine (HP:0002037) | 5.27054035 |
| 10 | Emphysema (HP:0002097) | 5.15052602 |
| 11 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 5.12215124 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.10286108 |
| 13 | Gastrointestinal inflammation (HP:0004386) | 5.01849668 |
| 14 | Verrucae (HP:0200043) | 4.88283595 |
| 15 | Papilloma (HP:0012740) | 4.88283595 |
| 16 | Recurrent viral infections (HP:0004429) | 4.82935898 |
| 17 | Petechiae (HP:0000967) | 4.68255165 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 4.67165211 |
| 19 | Epistaxis (HP:0000421) | 4.65595973 |
| 20 | IgA deficiency (HP:0002720) | 4.51249561 |
| 21 | Vasculitis (HP:0002633) | 4.48565205 |
| 22 | Meningitis (HP:0001287) | 4.41675781 |
| 23 | Chronic sinusitis (HP:0011109) | 4.24671428 |
| 24 | Abnormal platelet volume (HP:0011876) | 4.21845624 |
| 25 | Menorrhagia (HP:0000132) | 4.18223181 |
| 26 | Restrictive lung disease (HP:0002091) | 4.10885762 |
| 27 | Recurrent lower respiratory tract infections (HP:0002783) | 4.02390262 |
| 28 | Increased mean platelet volume (HP:0011877) | 4.01182217 |
| 29 | Purpura (HP:0000979) | 3.98906587 |
| 30 | Recurrent abscess formation (HP:0002722) | 3.96299252 |
| 31 | Recurrent pneumonia (HP:0006532) | 3.95859226 |
| 32 | Stomatitis (HP:0010280) | 3.91437881 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.87485705 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82379010 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82379010 |
| 36 | Chronic otitis media (HP:0000389) | 3.77572196 |
| 37 | Osteomyelitis (HP:0002754) | 3.61924908 |
| 38 | Recurrent otitis media (HP:0000403) | 3.56834702 |
| 39 | Recurrent fungal infections (HP:0002841) | 3.51472225 |
| 40 | Bronchitis (HP:0012387) | 3.50763079 |
| 41 | Small epiphyses (HP:0010585) | 3.43932449 |
| 42 | Abnormality of macrophages (HP:0004311) | 3.40869007 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 3.29720625 |
| 44 | Recurrent skin infections (HP:0001581) | 3.28753892 |
| 45 | Chronic diarrhea (HP:0002028) | 3.21762678 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19918774 |
| 47 | Myositis (HP:0100614) | 3.19157450 |
| 48 | Leukopenia (HP:0001882) | 3.18124212 |
| 49 | Optic neuritis (HP:0100653) | 3.18027621 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 3.18027621 |
| 51 | Mitral stenosis (HP:0001718) | 3.16182985 |
| 52 | Abnormality of the fingertips (HP:0001211) | 3.14753143 |
| 53 | Viral hepatitis (HP:0006562) | 3.07347437 |
| 54 | IgG deficiency (HP:0004315) | 3.06420439 |
| 55 | Thyroiditis (HP:0100646) | 3.06069268 |
| 56 | Abnormality of the prostate (HP:0008775) | 3.03815119 |
| 57 | B lymphocytopenia (HP:0010976) | 2.95509502 |
| 58 | Abnormality of B cell number (HP:0010975) | 2.95509502 |
| 59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.95398417 |
| 60 | Orchitis (HP:0100796) | 2.95118580 |
| 61 | Sepsis (HP:0100806) | 2.92948689 |
| 62 | Eczematoid dermatitis (HP:0000976) | 2.90335891 |
| 63 | Lymphoma (HP:0002665) | 2.89429639 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.85595650 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.80193542 |
| 66 | Leukocytosis (HP:0001974) | 2.75015026 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.73531210 |
| 68 | Increased IgM level (HP:0003496) | 2.72075856 |
| 69 | Abnormality of T cells (HP:0002843) | 2.69031196 |
| 70 | Abnormal platelet function (HP:0011869) | 2.67811703 |
| 71 | Impaired platelet aggregation (HP:0003540) | 2.67811703 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.65126246 |
| 73 | Granulocytopenia (HP:0001913) | 2.60583566 |
| 74 | Encephalitis (HP:0002383) | 2.56055601 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.54675812 |
| 76 | Hyperlipoproteinemia (HP:0010980) | 2.46140973 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.37039488 |
| 78 | Vertebral arch anomaly (HP:0008438) | 2.36538594 |
| 79 | Urticaria (HP:0001025) | 2.34761119 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.33944119 |
| 81 | T lymphocytopenia (HP:0005403) | 2.33591704 |
| 82 | Abnormality of T cell number (HP:0011839) | 2.32619143 |
| 83 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.31926049 |
| 84 | Obstructive lung disease (HP:0006536) | 2.29940034 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29940034 |
| 86 | Thrombocytosis (HP:0001894) | 2.29287416 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 2.28369725 |
| 88 | Joint swelling (HP:0001386) | 2.23664347 |
| 89 | Pulmonary embolism (HP:0002204) | 2.22873037 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.22770813 |
| 91 | Hypoplasia of the thymus (HP:0000778) | 2.21187889 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20898731 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.20312858 |
| 94 | Flattened epiphyses (HP:0003071) | 2.17889468 |
| 95 | Papilledema (HP:0001085) | 2.17156945 |
| 96 | Pustule (HP:0200039) | 2.16471383 |
| 97 | Skin ulcer (HP:0200042) | 2.13999994 |
| 98 | Arthralgia (HP:0002829) | 2.13750343 |
| 99 | Hemoptysis (HP:0002105) | 2.12676504 |
| 100 | Skin rash (HP:0000988) | 2.12095608 |
| 101 | Conjunctival telangiectasia (HP:0000524) | 2.10518291 |
| 102 | Hematochezia (HP:0002573) | 2.07533622 |
| 103 | Increased IgE level (HP:0003212) | 2.04814737 |
| 104 | Periodontitis (HP:0000704) | 2.04546459 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.04200033 |
| 106 | Nasal polyposis (HP:0100582) | 2.03542649 |
| 107 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.02395252 |
| 108 | Villous atrophy (HP:0011473) | 2.02395252 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.01549644 |
| 110 | Neutropenia (HP:0001875) | 2.00210151 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.97324700 |
| 112 | Stomach cancer (HP:0012126) | 1.96365299 |
| 113 | Visual hallucinations (HP:0002367) | 1.94625626 |
| 114 | Xerostomia (HP:0000217) | 1.92008361 |
| 115 | Poikilocytosis (HP:0004447) | 1.91590793 |
| 116 | Fatigue (HP:0012378) | 1.86318598 |
| 117 | Hepatitis (HP:0012115) | 1.86166816 |
| 118 | Irregular vertebral endplates (HP:0003301) | 1.84939054 |
| 119 | Arthropathy (HP:0003040) | 1.78642425 |
| 120 | Absent epiphyses (HP:0010577) | 1.78614352 |
| 121 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.78614352 |
| 122 | Myocardial infarction (HP:0001658) | 1.77215500 |
| 123 | Ulnar bowing (HP:0003031) | 1.77157087 |
| 124 | Resting tremor (HP:0002322) | 1.73386891 |
| 125 | Gingivitis (HP:0000230) | 1.66565753 |
| 126 | Prolonged bleeding time (HP:0003010) | 1.65475555 |
| 127 | Chest pain (HP:0100749) | 1.64647847 |
| 128 | Abnormality of the nasal mucosa (HP:0000433) | 1.63956387 |
| 129 | Acrocyanosis (HP:0001063) | 1.60422408 |
| 130 | Arterial thrombosis (HP:0004420) | 1.57338649 |
| 131 | Gingival bleeding (HP:0000225) | 1.55470136 |
| 132 | Basal cell carcinoma (HP:0002671) | 1.55382919 |
| 133 | Mucosal telangiectasiae (HP:0100579) | 1.53281498 |
| 134 | Eosinophilia (HP:0001880) | 1.52898179 |
| 135 | Abnormality of the intervertebral disk (HP:0005108) | 1.47168300 |
| 136 | Absent frontal sinuses (HP:0002688) | 1.45786311 |
| 137 | Aortic regurgitation (HP:0001659) | 1.45737495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 7.20074131 |
| 2 | BLK | 3.24201091 |
| 3 | GRK6 | 3.15364310 |
| 4 | CSF1R | 3.09310923 |
| 5 | MAP3K13 | 2.94084440 |
| 6 | RIPK4 | 2.85090642 |
| 7 | SYK | 2.75313815 |
| 8 | BTK | 2.66579443 |
| 9 | ERN1 | 2.61659631 |
| 10 | STK10 | 2.54530095 |
| 11 | LRRK2 | 2.53016382 |
| 12 | BMPR1B | 2.32769374 |
| 13 | TXK | 2.32167508 |
| 14 | MAP3K14 | 2.20544137 |
| 15 | TYK2 | 2.07419869 |
| 16 | JAK1 | 1.99928443 |
| 17 | MAP3K10 | 1.97378294 |
| 18 | IRAK1 | 1.83890848 |
| 19 | KIT | 1.81298107 |
| 20 | SIK2 | 1.80352531 |
| 21 | IRAK3 | 1.80121182 |
| 22 | LYN | 1.74361336 |
| 23 | GRK1 | 1.69306719 |
| 24 | CDK12 | 1.63178452 |
| 25 | TGFBR2 | 1.56854927 |
| 26 | CSK | 1.52341982 |
| 27 | MST4 | 1.49784532 |
| 28 | HCK | 1.49724890 |
| 29 | TEC | 1.38397988 |
| 30 | IKBKB | 1.36907517 |
| 31 | JAK3 | 1.35033762 |
| 32 | IRAK4 | 1.32910537 |
| 33 | CDK19 | 1.31209647 |
| 34 | PIK3CG | 1.29836497 |
| 35 | ITK | 1.26880192 |
| 36 | IRAK2 | 1.25968630 |
| 37 | PRKCQ | 1.25809730 |
| 38 | MARK3 | 1.25783581 |
| 39 | CLK1 | 1.19462745 |
| 40 | MATK | 1.18396674 |
| 41 | TBK1 | 1.17133070 |
| 42 | LCK | 1.12727345 |
| 43 | ZAP70 | 1.10315918 |
| 44 | SIK3 | 1.09544175 |
| 45 | EEF2K | 1.07887972 |
| 46 | EIF2AK3 | 1.07637699 |
| 47 | FES | 1.05065198 |
| 48 | PTK2B | 1.04497398 |
| 49 | PRKCH | 1.02490957 |
| 50 | BRD4 | 1.01416460 |
| 51 | CDC42BPA | 0.97952637 |
| 52 | FGFR3 | 0.96207313 |
| 53 | CAMK1D | 0.92684895 |
| 54 | BMX | 0.90988774 |
| 55 | IKBKE | 0.90055178 |
| 56 | TESK2 | 0.89956509 |
| 57 | PIM1 | 0.87552521 |
| 58 | CAMK1G | 0.84864751 |
| 59 | MAP3K3 | 0.83462906 |
| 60 | CHUK | 0.82779251 |
| 61 | TNK2 | 0.78949628 |
| 62 | MAPK7 | 0.77659363 |
| 63 | MAP3K9 | 0.77345662 |
| 64 | TRPM7 | 0.76199391 |
| 65 | FRK | 0.74545694 |
| 66 | FGFR4 | 0.69214883 |
| 67 | RPS6KA4 | 0.63841742 |
| 68 | ALK | 0.63580230 |
| 69 | CCNB1 | 0.63227706 |
| 70 | HIPK2 | 0.62806816 |
| 71 | FGR | 0.62570267 |
| 72 | PRPF4B | 0.60459191 |
| 73 | MAPK12 | 0.60438735 |
| 74 | PDK1 | 0.59854347 |
| 75 | MYLK | 0.59224887 |
| 76 | GRK5 | 0.59165858 |
| 77 | SIK1 | 0.58004211 |
| 78 | ACVR1B | 0.57964121 |
| 79 | ABL1 | 0.57727472 |
| 80 | CDK9 | 0.56092955 |
| 81 | ADRBK2 | 0.54738990 |
| 82 | MELK | 0.53708637 |
| 83 | TAOK1 | 0.51626258 |
| 84 | MARK2 | 0.50968355 |
| 85 | PRKD2 | 0.50847043 |
| 86 | MAP3K1 | 0.50265995 |
| 87 | INSR | 0.50088932 |
| 88 | PDPK1 | 0.49845458 |
| 89 | MAPKAPK3 | 0.49409991 |
| 90 | NEK2 | 0.47757397 |
| 91 | TLK1 | 0.46755259 |
| 92 | FYN | 0.46062313 |
| 93 | SGK3 | 0.44747874 |
| 94 | CDK4 | 0.43753707 |
| 95 | EGFR | 0.40605083 |
| 96 | PASK | 0.39400866 |
| 97 | PRKCD | 0.38911671 |
| 98 | WNK1 | 0.38418585 |
| 99 | CSNK1A1L | 0.38015496 |
| 100 | MAP2K3 | 0.37563886 |
| 101 | STK4 | 0.35987151 |
| 102 | BMPR2 | 0.34616867 |
| 103 | MAP2K2 | 0.34393748 |
| 104 | JAK2 | 0.34005281 |
| 105 | PRKCI | 0.33157706 |
| 106 | CDK6 | 0.32960640 |
| 107 | MAP3K8 | 0.32728804 |
| 108 | MAPKAPK2 | 0.31021312 |
| 109 | MAP3K11 | 0.30628238 |
| 110 | MAP3K7 | 0.30469678 |
| 111 | CAMKK1 | 0.30015561 |
| 112 | ADRBK1 | 0.29913084 |
| 113 | EPHB1 | 0.28741375 |
| 114 | TAOK3 | 0.28168341 |
| 115 | PRKD1 | 0.27812283 |
| 116 | NUAK1 | 0.27652121 |
| 117 | CDK3 | 0.27634554 |
| 118 | IGF1R | 0.27497303 |
| 119 | CAMKK2 | 0.26995846 |
| 120 | CDK8 | 0.26614372 |
| 121 | TGFBR1 | 0.25797575 |
| 122 | ATR | 0.25380779 |
| 123 | NEK9 | 0.23134879 |
| 124 | SCYL2 | 0.22496537 |
| 125 | CSNK1G1 | 0.22438322 |
| 126 | MAPK11 | 0.22205296 |
| 127 | SGK2 | 0.20359216 |
| 128 | NLK | 0.20045621 |
| 129 | PTK6 | 0.19728975 |
| 130 | PKN1 | 0.19110657 |
| 131 | DYRK1B | 0.18425311 |
| 132 | YES1 | 0.17976263 |
| 133 | TTN | 0.17856535 |
| 134 | MAPK3 | 0.17355653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.41766902 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.30836219 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.89493966 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70903197 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 3.41092577 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.10409176 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.92172269 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.88952276 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29294354 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.27348911 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19862545 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.03932109 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.84580976 |
| 14 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82358612 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77700977 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.58885336 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56152063 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52531087 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51780891 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.50796493 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.50290559 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.41499884 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40701761 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30640578 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27185023 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27173333 |
| 27 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26493857 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25147742 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21872115 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16563038 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.15407675 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.13455317 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13429373 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.12799973 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.12116224 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.12104921 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10167762 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.10021165 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08540244 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.04641208 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04058606 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98992304 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98900681 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97123669 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 0.94815499 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91728633 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90193526 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90037766 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85350260 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84300038 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83739529 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.83303362 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83093783 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82343578 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.79516897 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78442951 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.77711854 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75080332 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.74428267 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74332663 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70537996 |
| 62 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69638323 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.68893378 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.67939320 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.66445686 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65565458 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64181527 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62792160 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.61637512 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61604374 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.60335213 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59386932 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57711936 |
| 74 | Homologous recombination_Homo sapiens_hsa03440 | 0.56644164 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55605999 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54533389 |
| 77 | Allograft rejection_Homo sapiens_hsa05330 | 0.54062845 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51760434 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50871210 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50708620 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50513282 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.50212252 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50067390 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49307220 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48924134 |
| 86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48836358 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48188837 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47852058 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47483117 |
| 90 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47220284 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45812542 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44099464 |
| 93 | Legionellosis_Homo sapiens_hsa05134 | 0.42382970 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.42255732 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.42106924 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.40990889 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.40969189 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40263060 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39716931 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38268956 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37940074 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37815983 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36410907 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36183875 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35752380 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35067762 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34349611 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34251757 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34164914 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33707021 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.31591748 |
| 112 | Morphine addiction_Homo sapiens_hsa05032 | 0.31180462 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30450958 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29766571 |
| 115 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28994407 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28715822 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28373713 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27461046 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.26498890 |
| 120 | Ribosome_Homo sapiens_hsa03010 | 0.26197410 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25180793 |
| 122 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.24825118 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24578063 |
| 124 | Spliceosome_Homo sapiens_hsa03040 | 0.24444178 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.24251633 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.23412255 |
| 127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22032453 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19679515 |
| 129 | Long-term depression_Homo sapiens_hsa04730 | 0.19416864 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17387052 |
| 131 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.14766485 |
| 132 | Gap junction_Homo sapiens_hsa04540 | 0.13891452 |

